{{Rsnum
|rsid=258671
|Gene=CACNA2D1
|Chromosome=7
|position=82102130
|Orientation=plus
|GMAF=0.371
|Gene_s=CACNA2D1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 39.8 | 46.9 | 13.3
| HCB | 40.4 | 43.4 | 16.2
| JPT | 25.7 | 52.2 | 22.1
| YRI | 55.8 | 38.8 | 5.4
| ASW | 47.4 | 36.8 | 15.8
| CHB | 40.4 | 43.4 | 16.2
| CHD | 30.3 | 51.4 | 18.3
| GIH | 29.7 | 59.4 | 10.9
| LWK | 70.9 | 25.5 | 3.6
| MEX | 20.7 | 62.1 | 17.2
| MKK | 55.8 | 39.1 | 5.1
| TSI | 38.2 | 48.0 | 13.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=1E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}